Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Genetically proxied inhibition of angiotensinogen synthesis is associated with lower cardiovascular risk

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Tue, 03/10/2026 - 16:23
  • Read more about Genetically proxied inhibition of angiotensinogen synthesis is associated with lower cardiovascular risk

Identification of circadian rhythm-related genes in colorectal cancer by integrating bioinformatics and multi-omics mendelian randomization

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Tue, 03/10/2026 - 11:29
  • Read more about Identification of circadian rhythm-related genes in colorectal cancer by integrating bioinformatics and multi-omics mendelian randomization

Evaluation of Potential Therapeutic Targets for Bacterial Infectious Skin Diseases: A Proteome-Wide Mendelian Randomization Study

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Tue, 03/10/2026 - 11:28
  • Read more about Evaluation of Potential Therapeutic Targets for Bacterial Infectious Skin Diseases: A Proteome-Wide Mendelian Randomization Study

Investigating the causal association between plasma lipids and the risk of squamous cervical cancer: A two-sample mendelian randomization study

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Tue, 03/10/2026 - 11:27
  • Read more about Investigating the causal association between plasma lipids and the risk of squamous cervical cancer: A two-sample mendelian randomization study

The impact of combined spinal-epidural analgesia (CSEA) on postpartum depression: A Mendelian randomization study

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Tue, 03/10/2026 - 11:25
  • Read more about The impact of combined spinal-epidural analgesia (CSEA) on postpartum depression: A Mendelian randomization study

Causal relationship between renin-angiotensin system inhibitors and cancer: a two-sample, two-step Mendelian randomization study

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Tue, 03/10/2026 - 11:24
  • Read more about Causal relationship between renin-angiotensin system inhibitors and cancer: a two-sample, two-step Mendelian randomization study

POLK and KCNK17 as novel candidate genes for type 2 diabetes via stress response and ion channel regulation

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Tue, 03/10/2026 - 11:21
  • Read more about POLK and KCNK17 as novel candidate genes for type 2 diabetes via stress response and ion channel regulation

Association Between Unsaturated Fatty Acid Levels and Chronic Obstructive Pulmonary Disease: A Bidirectional Mendelian Randomization Study

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Tue, 03/10/2026 - 11:14
  • Read more about Association Between Unsaturated Fatty Acid Levels and Chronic Obstructive Pulmonary Disease: A Bidirectional Mendelian Randomization Study

Genomic and proteomic insights into hidradenitis suppurativa

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Tue, 03/10/2026 - 11:13
  • Read more about Genomic and proteomic insights into hidradenitis suppurativa

Finnish-Enriched SLC26A7 Variant in Congenital Hypothyroidism: Clinical Spectrum, Thyroid Histopathology, and Expression Analysis

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Tue, 03/10/2026 - 10:44
  • Read more about Finnish-Enriched SLC26A7 Variant in Congenital Hypothyroidism: Clinical Spectrum, Thyroid Histopathology, and Expression Analysis

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 63
  • Page 64
  • Page 65
  • Page 66
  • Current page 67
  • Page 68
  • Page 69
  • Page 70
  • Page 71
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social
Follow us on LinkedIn
https://www.linkedin.com/company/finngen/

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement